EUROESPES — Investor Relations & Filings

Euroespes is a biomedical research center and medical services provider specializing in Genomic and Personalized Medicine. The company focuses on the research, diagnosis, treatment, and prevention of diseases, with a primary emphasis on disorders of the central nervous system, such as Alzheimer's and Parkinson's disease. Its scope also extends to other prevalent conditions, including cancer and metabolic syndromes. Leveraging its expertise in pharmacogenomics, Euroespes develops novel bioproducts and implements personalized prevention and treatment programs, positioning itself as an international reference center in its field.